Journal of Cachexia, Sarcopenia and Muscle, Vol 12, Iss 6, Pp 1501-1512 (2021) Journal of Cachexia, Sarcopenia and Muscle
ISSN:
2190-5991 2190-6009
Popis:
Background Pulmonary arterial hypertension (PAH) is a progressive disease with limited survival. Iron deficiency (ID) correlates with disease severity and mortality. While oral iron supplementation was shown to be insufficient in such patients, the potential impact of parenteral iron on clinical measures warrants further investigation. Methods We retrospectively analysed the long‐term effects of intravenous ferric carboxymaltose (FCM) on iron status and clinical measures in patients with PAH and ID [ferritin